Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Lorus Therapeutics, Inc. (LOR) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Lorus Therapeutics is a biopharmaceutical company focused on the discovery, research and development of pharmaceutical products and technologies for managing cancer. The company’s aim is to capitalize on its research and preclinical, clinical and regulatory expertise through the development of new drug candidates that can be used – either alone or combined with other drugs – for the successful management of cancer. Lorus additionally has expertise in antimicrobial drug discovery. For more information, visit the company’s Web site at www.lorusthera.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below:

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.
This entry was posted in Rodman and Renshaw Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *